InvestorsHub Logo
Followers 472
Posts 37018
Boards Moderated 0
Alias Born 01/11/2004

Re: Jaguarjacket post# 62194

Friday, 05/07/2021 1:36:24 PM

Friday, May 07, 2021 1:36:24 PM

Post# of 118383
Regen is also engaged in the identification of small molecules which activate the NR2F6 nuclear receptor that can be utilized to develop small molecule therapies for autoimmune disorders.

https://seekingalpha.com/amp/news/3693137-oncology-pharma-inks-license-agreement-with-regen-biopharma